Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hariom Singh

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Microbial Pathogenesis|September 2, 2022
Role of MMP-13-77A/G polymorphism in HIV-associated neurocognitive disorders patientsHariOm Singh, Kishore Dhotre
Current HIV Research|September 12, 2022
TLR3 polymorphisms in HIV infected individuals naïve to ARTHariOm Singh, Dharmesh Samani
Microbial Pathogenesis|June 5, 2018
Occurrence of APOBEC3G variations in West Indian HIV patientsHariOm Singh, R R Gangakhedkar
Microbial Pathogenesis|October 17, 2021
KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicityHariOm Singh, Dharmesh Samani, Sushama Jadhav
Oncology Research|November 17, 2009
Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancerHariom Singh, Meenu Jain, Balraj Mittal
Mediators of Inflammation|June 23, 2020
TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ARTHariOm Singh, Dharmesh Samani, Sumit Aggarwal
Microbial Pathogenesis|September 4, 2021
Impact of MBL-2 coding region polymorphism on modulation of HAND and HIV-1 acquisitionHariOm Singh, Sushama Jadhav, Vijay Chauware
Gynecologic Oncology|May 2, 2008
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancerHariOm Singh, Meenu Jain, Balraj Mittal
The Journal of Gene Medicine|March 2, 2023
Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophyShyamveer, Abdul Arif Khan, HariOm Singh
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 26, 2018
Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patientsHariOm Singh, Sonam Lata, Raman R Gangakhedkar
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Microbial Pathogenesis|September 2, 2022
Role of MMP-13-77A/G polymorphism in HIV-associated neurocognitive disorders patientsHariOm Singh, Kishore Dhotre
Current HIV Research|September 12, 2022
TLR3 polymorphisms in HIV infected individuals naïve to ARTHariOm Singh, Dharmesh Samani
Microbial Pathogenesis|June 5, 2018
Occurrence of APOBEC3G variations in West Indian HIV patientsHariOm Singh, R R Gangakhedkar
Microbial Pathogenesis|October 17, 2021
KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicityHariOm Singh, Dharmesh Samani, Sushama Jadhav
Oncology Research|November 17, 2009
Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancerHariom Singh, Meenu Jain, Balraj Mittal
Mediators of Inflammation|June 23, 2020
TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ARTHariOm Singh, Dharmesh Samani, Sumit Aggarwal
Microbial Pathogenesis|September 4, 2021
Impact of MBL-2 coding region polymorphism on modulation of HAND and HIV-1 acquisitionHariOm Singh, Sushama Jadhav, Vijay Chauware
Gynecologic Oncology|May 2, 2008
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancerHariOm Singh, Meenu Jain, Balraj Mittal
The Journal of Gene Medicine|March 2, 2023
Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophyShyamveer, Abdul Arif Khan, HariOm Singh
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 26, 2018
Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patientsHariOm Singh, Sonam Lata, Raman R Gangakhedkar
Pageof 6